Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Editorial Board of Cancer Genomics & Proteomics 2023

A. Seth

Editor-in-chief, Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada

G. J.  Delinasios

Managing Editor and Executive Publisher, International Institute of Anticancer Research, Athens, Greece

L.A. Aaltonen

Department of Medical Genetics, University of Helsinki, Finland

R. Abagyan

The Scripps Research Institute, La Jolla, CA, USA

D.T. Bau

Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan

R. Clarke

Vincent T. Lombardi Cancer Center, Georgetown Univ. School of Medicine, Washington, DC, USA

Α.Μ. Dubuc

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

T. Efferth

Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Germany

N.A. Ellis

Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, AZ, USA

A. Facoetti

Fondazione CNAO, Pavia, Italy

C.V. Forst

Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

G. Glinsky

Institute of Engineering in Medicine, University of California, San Diego, CA, USA

T.R. Golub

Pediatric Oncology, Dana-Farber Cancer Institute, Cambridge, MA, USA

J. Gordon

Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA

C.H. Heldin

Ludwig Institute for Cancer Research, Uppsala, Sweden

J.D. Hoheisel

Deutsches Krebsforschungszentrum, Genome Research and Bioinformatics, Heidelberg, Germany

T.H.M. Huang

Department of Molecular Medicine / Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

S.C. Jhanwar

Departments of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

J. Ju

Translational Research Laboratory, State University of New York-Stony Brook, School of Medicine, Stony Brook, NY, USA

O.P. Kallioniemi

Medical Biotechnology Group, VTT Technical Research Centre of Finland, Turku, Finland

K. Khalili

College of Science and Technology, Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, PA, USA

D.G. Kieback

Helios Medical Center Schleswig, Schleswig, Germany

S.D. Kottaridis

Department of Virology, Hellenic Anticancer Institute, Athens, Greece

Y. T. Kwon

Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea

B. Leyland – Jones

National Foundation for Cancer Research (NFCR), Rockville, MD, USA

P. Lichter

Deutsches Krebsforschungszentrum, Heidelberg, Germany

A. Lindblom

Karolinska Hospital, Department of Molecular Medicine and Surgery, Stockholm, Sweden

G. Lubec

Department of Pediatrics, University of Vienna, Austria

P.J. McCormick

The Center for Functional Genomics, Gen*NY*Sis Center for Excellence in Cancer Genomics, University of Albany, SUNY, Rensselaer, NY, USA

F. Mitelman

Department of Clinical Genetics, University Hospital, Lund, Sweden

C. Nicot

Department of Microbiology, Immunology and Molecular Genetics, University of Kansas Medical Center, Kansas City, KS, USA

L. O’ Driscoll

School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland

C.D. Platsoucas

College of Sciences, Old Dominion University, Norfolk, VA, USA

J. Quackenbush

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA

J.S. Rader

Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA

R.H. Reeves

Department of Physiology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA

T. Ried

Center for Cancer Research, Genetics Branch, NCI, NIH, Bethesda, MD, USA

G. Rimbach

Institute of Human Nutrition and Food Science, Christian-Albrechts-Univercity, Kiel, Germany

K.D. Rodland

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA

C. Sansom

The School of Crystallography, Birbeck College, University of London, UK

N.A. Saunders

Centre for Immunology & Cancer Research, Princess Alexandra Hospital, University of Queensland, Australia

B.W. Schaefer

Department of Oncology, University Children’s Hospital, Zurich, Switzerland

J. Schneider

Universidad de Valladolid, Valladolid, Spain

O.J. Semmes

Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA, USA

G.V. Sherbet

University of Newcastle, Merz Court, Department of Electrical and Electronic Engineering, Newcastle upon Tyne, UK

S. Smith

City of Hope Cancer Center, Department of Cell and Tumor Biology, Duarte, CA, USA

J.C. Strefford

Cancer Science Division, Southampton General Hospital, Southampton, UK

G. Tsangaris

Foundation of Biomedical Research of the Academy of Athens, Central Unit of Genomics- Proteomics, Athens, Greece

U.H. Weidle

Roche Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, Penzberg, Germany

H. Zhang

Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA

 

Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire